Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Rindone E and Rosset L
Idiopathic pulmonary fibrosis (IPF) is still a non-curable disease. The suggested therapy consists of Pirfenidone combined with other drugs like azathioprine, and acetylcysteine. The New England Journal of Medicine published a new study that goes against the common use of N-acetylcysteine (NAC) to treat IPF patient. There are other studies that went in favor of N-acetylcysteine. The present study reviews the entire developments and sums up the reality by affirming that new studies should be done to demonstrate whether the NAC should be administered in combination with Pirfenidone or not, as the last study did not clarify this point.
You can submit articles in our peer reviewed Journal at http://scitechnol.com/submitmanuscript.php
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi